HCV treatment duration in HIV/HCV genotype 1 co-infected patients. Results of a multicenter randomized trial (2010)
- Authors:
- Autor USP: BARONE, ANTONIO ALCI - FM
- Unidade: FM
- Subjects: HOSPEDEIRO IMUNOCOMPROMETIDO; INFECÇÕES POR HIV; GENÓTIPOS; RESUMOS (EVENTOS); HEPATITE C (VIROLOGIA); HEPATITE VIRAL HUMANA
- Language: Inglês
- Imprenta:
- Source:
- Título: Hepatology
- ISSN: 0270-9139
- Volume/Número/Paginação/Ano: v. 52, n. 4 (suppl), p. 361A, res. 83, 2010
-
ABNT
BARONE, Antonio A. et al. HCV treatment duration in HIV/HCV genotype 1 co-infected patients. Results of a multicenter randomized trial. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/hep.23974/pdf. Acesso em: 10 jan. 2026. , 2010 -
APA
Barone, A. A., Cheinquer, H., Brandão-Mello, C. E., & Marins, E. G. (2010). HCV treatment duration in HIV/HCV genotype 1 co-infected patients. Results of a multicenter randomized trial. Hepatology. Baltimore: Faculdade de Medicina, Universidade de São Paulo. Recuperado de http://onlinelibrary.wiley.com/doi/10.1002/hep.23974/pdf -
NLM
Barone AA, Cheinquer H, Brandão-Mello CE, Marins EG. HCV treatment duration in HIV/HCV genotype 1 co-infected patients. Results of a multicenter randomized trial [Internet]. Hepatology. 2010 ; 52( 4 (suppl): 361A.[citado 2026 jan. 10 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/hep.23974/pdf -
Vancouver
Barone AA, Cheinquer H, Brandão-Mello CE, Marins EG. HCV treatment duration in HIV/HCV genotype 1 co-infected patients. Results of a multicenter randomized trial [Internet]. Hepatology. 2010 ; 52( 4 (suppl): 361A.[citado 2026 jan. 10 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/hep.23974/pdf - Weigt-based combination therapy with peginterferon alfa 2b and ribavirin for naïve, relapser and non-responder patients with chronic hepatitis C
- Patients with chronic hepatitis C and normal transaminases
- Clinical classification of tetanus patients
- Hepatite C
- Therapeutic perspectives for hepatitis C
- Hepatite B
- The interleukin-10 - 1082 G/A promoter polymorphism and the outcome of HCV infection
- Expectoration of large bronchial casts secondary to the treatment of chronic hepatitis C with pegylated interferon and ribavirin [Carta]
- Sangue seguro [Editorial]: mito ou realidade?
- Sociedade paulista de infectologia realiza I consenso de manuseio e terapia da hepatite C [Entrevista]
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
